--- title: "Arcosa 投資者警報：Kahn Swick & Foti, LLC 正在調查擬議出售 Arcosa, Inc. - ACA 的價格和流程是否合理" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/296132830.md" description: "Kahn Swick & Foti, LLC 正在調查 Arcosa, Inc. 擬議出售給 CRH 的事宜，以確定每股 150 美元的現金報價及交易過程是否足夠或低估了該公司。對潛在低估感到擔憂的股東或希望討論其法律權利的股東，鼓勵通過電子郵件或電話聯繫管理合夥人 Lewis S. Kahn" datetime: "2026-08-17T17:13:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296132830.md) - [en](https://longbridge.com/en/news/296132830.md) - [zh-HK](https://longbridge.com/zh-HK/news/296132830.md) generator: "portal-rs" --- # Arcosa 投資者警報：Kahn Swick & Foti, LLC 正在調查擬議出售 Arcosa, Inc. - ACA 的價格和流程是否合理 Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Arcosa, Inc. (NYSE: ACA) to CRH (NYSE: CRH). Under the terms of the proposed transaction, shareholders of Arcosa will receive $150.00 in cash for each share of Arcosa that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 833-538-3612, or visit https://www.ksfcounsel.com/cases/nyse-aca/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn Kahn Swick & Foti, LLC Lewis S. Kahn, Managing Partner lewis.kahn@ksfcounsel.com 833-538-3612 1100 Poydras St., Suite 960 New Orleans, LA 70163 View source version on businesswire.com: https://www.businesswire.com/news/home/20260817369437/en/ ### 相關股票 - [ACA.US](https://longbridge.com/zh-HK/quote/ACA.US.md) - [CRH.US](https://longbridge.com/zh-HK/quote/CRH.US.md) - [CRH.UK](https://longbridge.com/zh-HK/quote/CRH.UK.md) ## 相關資訊與研究 - [Arcosa 股東批准 CRH 的收購 | ACA 股票新聞](https://longbridge.com/zh-HK/news/298073047.md) - [Arcosa, Inc. 宣佈季度分紅 | ACA 股票新聞](https://longbridge.com/zh-HK/news/297829833.md) - [Apnimed, Inc. 公佈了第二季度的業績](https://longbridge.com/zh-HK/news/298366495.md) - [Braveheart Bio, Inc.公佈了第二季度的業績報告](https://longbridge.com/zh-HK/news/298361396.md) - [ONEnergy Inc. 未知曉任何重大變化](https://longbridge.com/zh-HK/news/299080052.md) --- > **免責聲明: 本文僅供參考，不構成任何投資建議。**